IRMD
Price
$55.05
Change
+$1.70 (+3.19%)
Updated
Dec 20, 04:59 PM (EDT)
47 days until earnings call
MTD
Price
$1230.67
Change
+$24.65 (+2.04%)
Updated
Dec 20, 04:59 PM (EDT)
47 days until earnings call
Ad is loading...

IRMD vs MTD

Header iconIRMD vs MTD Comparison
Open Charts IRMD vs MTDBanner chart's image
iRadimed
Price$55.05
Change+$1.70 (+3.19%)
Volume$100
CapitalizationN/A
Mettler-Toledo International
Price$1230.67
Change+$24.65 (+2.04%)
Volume$600
CapitalizationN/A
IRMD vs MTD Comparison Chart
Loading...
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRMD vs. MTD commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRMD is a Hold and MTD is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (IRMD: $54.65 vs. MTD: $1230.74)
Brand notoriety: IRMD and MTD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IRMD: 216% vs. MTD: 168%
Market capitalization -- IRMD: $557.04M vs. MTD: $28.69B
IRMD [@Medical Specialties] is valued at $557.04M. MTD’s [@Medical Specialties] market capitalization is $28.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRMD’s FA Score shows that 2 FA rating(s) are green whileMTD’s FA Score has 1 green FA rating(s).

  • IRMD’s FA Score: 2 green, 3 red.
  • MTD’s FA Score: 1 green, 4 red.
According to our system of comparison, IRMD is a better buy in the long-term than MTD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRMD’s TA Score shows that 4 TA indicator(s) are bullish while MTD’s TA Score has 5 bullish TA indicator(s).

  • IRMD’s TA Score: 4 bullish, 2 bearish.
  • MTD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, IRMD is a better buy in the short-term than MTD.

Price Growth

IRMD (@Medical Specialties) experienced а +3.84% price change this week, while MTD (@Medical Specialties) price change was -3.62% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

IRMD is expected to report earnings on Feb 06, 2025.

MTD is expected to report earnings on Feb 06, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MTD($28.7B) has a higher market cap than IRMD($557M). MTD has higher P/E ratio than IRMD: MTD (37.36) vs IRMD (31.84). IRMD YTD gains are higher at: 16.245 vs. MTD (1.466). MTD has higher annual earnings (EBITDA): 1.17B vs. IRMD (20.8M). MTD has more cash in the bank: 69.8M vs. IRMD (49.8M). IRMD has less debt than MTD: IRMD (2.04M) vs MTD (2.08B). MTD has higher revenues than IRMD: MTD (3.79B) vs IRMD (65.6M).
IRMDMTDIRMD / MTD
Capitalization557M28.7B2%
EBITDA20.8M1.17B2%
Gain YTD16.2451.4661,108%
P/E Ratio31.8437.3685%
Revenue65.6M3.79B2%
Total Cash49.8M69.8M71%
Total Debt2.04M2.08B0%
FUNDAMENTALS RATINGS
IRMD vs MTD: Fundamental Ratings
IRMD
MTD
OUTLOOK RATING
1..100
7385
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
97
Overvalued
PROFIT vs RISK RATING
1..100
2244
SMR RATING
1..100
403
PRICE GROWTH RATING
1..100
4359
P/E GROWTH RATING
1..100
4151
SEASONALITY SCORE
1..100
2550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IRMD's Valuation (15) in the Medical Specialties industry is significantly better than the same rating for MTD (97). This means that IRMD’s stock grew significantly faster than MTD’s over the last 12 months.

IRMD's Profit vs Risk Rating (22) in the Medical Specialties industry is in the same range as MTD (44). This means that IRMD’s stock grew similarly to MTD’s over the last 12 months.

MTD's SMR Rating (3) in the Medical Specialties industry is somewhat better than the same rating for IRMD (40). This means that MTD’s stock grew somewhat faster than IRMD’s over the last 12 months.

IRMD's Price Growth Rating (43) in the Medical Specialties industry is in the same range as MTD (59). This means that IRMD’s stock grew similarly to MTD’s over the last 12 months.

IRMD's P/E Growth Rating (41) in the Medical Specialties industry is in the same range as MTD (51). This means that IRMD’s stock grew similarly to MTD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IRMDMTD
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
69%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
57%
MACD
ODDS (%)
Bearish Trend 1 day ago
54%
Bearish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
64%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
63%
Advances
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 9 days ago
61%
Declines
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 3 days ago
63%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
64%
View a ticker or compare two or three
Ad is loading...
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NKTX2.370.17
+7.73%
Nkarta
MGM34.160.72
+2.15%
MGM Resorts International
BWMX10.990.07
+0.64%
Betterware de Mexico SAPI de CV
SGMA1.54-0.05
-3.14%
SigmaTron International
ARCH137.73-5.90
-4.11%
Arch Resources

IRMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with LUNG. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then LUNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
+2.44%
LUNG - IRMD
42%
Loosely correlated
+3.88%
HBIO - IRMD
40%
Loosely correlated
+0.24%
BLFS - IRMD
38%
Loosely correlated
+4.83%
CRL - IRMD
38%
Loosely correlated
+1.99%
GKOS - IRMD
37%
Loosely correlated
+4.97%
More

MTD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTD
1D Price
Change %
MTD100%
+2.05%
A - MTD
73%
Closely correlated
+0.99%
WAT - MTD
66%
Closely correlated
+2.09%
TMO - MTD
64%
Loosely correlated
+1.42%
RVTY - MTD
54%
Loosely correlated
+1.83%
DHR - MTD
53%
Loosely correlated
+1.06%
More